Details

Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč : doktorsko delo
ID Humar, Mojca (Author), ID Čufer, Tanja (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,15 MB)
MD5: FC691BCFDFB33501F247F274E20ADF12
PID: 20.500.12556/rul/9136d6e5-a24e-4350-b1cb-75b7537460ae

Language:Slovenian
Keywords:onkologija, nedrobnocelični karcinom pljuč, receptor za IGF tipa 1, sladkorna bolezen tip 2, stopnja preživetja, imunohistokemija, bioločki tumorski označevalci
Work type:Dissertation
Typology:2.08 - Doctoral Dissertation
Organization:MF - Faculty of Medicine
Place of publishing:Ljubljana
Publisher:[M. Humar]
Year:2017
Number of pages:49 f.
PID:20.500.12556/RUL-99262 This link opens in a new window
UDC:616.24-006-036(043.3)
COBISS.SI-ID:293271808 This link opens in a new window
Publication date in RUL:10.01.2018
Views:3739
Downloads:620
Metadata:XML DC-XML DC-RDF
:
HUMAR, Mojca, 2017, Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč : doktorsko delo [online]. Doctoral dissertation. Ljubljana : M. Humar. [Accessed 25 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=99262
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Keywords:oncology, carcinoma non-small-cell lung, receptor IGF type 1, diabetes mellitus type 2, survival rate, immunohistochemistry, biomarkers tumor

Similar documents

Similar works from RUL:
  1. European union enlargement to the East
  2. Ann L. Phillips: Power and influence after the Cold War: Germany in East Central Europe
  3. Learning by interacting and catching up in Central and Eastern European countries
  4. Demografski problemi tranzicijskih držav
  5. Factors of Stabilisation of Democracy in Central and Eastern European Countries
Similar works from other Slovenian collections:
  1. Transition report
  2. NSCLC molecular testing in Central and Eastern European countries
  3. European business
  4. Expenditures on oncology drugs and cancer mortality-to-incidence ratio in Central and Eastern Europe
  5. Enterprises in Europe

Back